Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study.
Visco C, Rodeghiero F, Romano A, Valeri F, Merli M, Quaresimini G, Volpetti S, Santi RM, Carli G, Lucchini E, Passamonti F, Rambaldi A, Motta G, Borchiellini A, d'Amore ESG, Ruggeri M.
Visco C, et al. Among authors: valeri f.
Blood. 2019 Nov 14;134(20):1708-1711. doi: 10.1182/blood.2019001617.
Blood. 2019.
PMID: 31570488
Free article.
Clinical Trial.